CALC20260717C7
CALC Jul 17 2026 7.00 Call (CALC260717C00007000)
option OPRA

calcimedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of autoimmune disorders, organ transplant rejection, and other immune diseases.